BCRX Biocryst Pharmaceuticals Inc

Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.

$10.58  -0.23 (-2.13%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/07/2001
Outstanding shares:  185,583,896
Average volume:  3,430,410
Market cap:   $2,006,161,916
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2100362
Valuation   (See tab for details)
PE ratio:   -10.12
PB ratio:   55.39
PS ratio:   10.67
Return on equity:   118.12%
Net income %:   -103.16%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy